Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ESCITALOPRAM OXALATE Cause Benign prostatic hyperplasia? 7 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Benign prostatic hyperplasia have been filed in association with ESCITALOPRAM OXALATE (Escitalopram). This represents 0.0% of all adverse event reports for ESCITALOPRAM OXALATE.

7
Reports of Benign prostatic hyperplasia with ESCITALOPRAM OXALATE
0.0%
of all ESCITALOPRAM OXALATE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From ESCITALOPRAM OXALATE?

Of the 7 reports, 2 (28.6%) required hospitalization.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ESCITALOPRAM OXALATE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does ESCITALOPRAM OXALATE Cause?

Drug ineffective (2,792) Anxiety (1,686) Headache (1,643) Somnolence (1,640) Nausea (1,635) Completed suicide (1,504) Drug interaction (1,477) Toxicity to various agents (1,446) Fatigue (1,443) Off label use (1,422)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which ESCITALOPRAM OXALATE Alternatives Have Lower Benign prostatic hyperplasia Risk?

ESCITALOPRAM OXALATE vs ESKETAMINE ESCITALOPRAM OXALATE vs ESLICARBAZEPINE ESCITALOPRAM OXALATE vs ESMOLOL ESCITALOPRAM OXALATE vs ESOMEPRAZOLE ESCITALOPRAM OXALATE vs ESOMEPRAZOLE\ESOMEPRAZOLE\ESOMEPRAZOLE

Related Pages

ESCITALOPRAM OXALATE Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia ESCITALOPRAM OXALATE Demographics